18F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer

International Journal of Clinical Oncology

Volumn 15, Issue 2, 2010, Pages 184-190

  Jingu, Keiichi ^a   Kaneta, Tomohiro ^a   Nemoto, Kenji ^b   Takeda, Ken ^a   Ogawa, Yoshihiro ^a   Ariga, Hisanori ^a   Koto, Masashi ^a   Sakayauchi, Toru ^a   Takai, Yoshihiro ^a   Takahashi, Shoki ^a   Yamada, Shogo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

FDG PET; Prognosis; Radiotherapy; Recurrent esophageal cancer; SUV max

Indexed keywords

DOCETAXEL; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; NEDAPLATIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SURVIVAL RATE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950942627     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-010-0044-y     Document Type: Article

References (30)

1. P Flamen A Lerut E Van Cutsem, et al. 2000 The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer J Thorac Cardiovasc Surg 120 1085 1092 10.1067/mtc.2000.110464 1:STN:280:DC%2BD3M%2FntF2ntA%3D%3D 11088030
2. H Kato T Miyazaki M Nakajima, et al. 2004 Value of positron emission tomography in the diagnosis of recurrent oesohageal carcinoma Br J Surg 91 1004 1009 10.1002/bjs.4595 1:STN:280:DC%2BD2czot1Cisw%3D%3D 15286962 (Pubitemid 39070815)
3. CP Duong H Demitriou L Weih, et al. 2006 Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer Eur J Nucl Med Mol Imaging 33 759 769 10.1007/s00259-005-0028-8 16470369 (Pubitemid 43979683)
4. H Kato H Kuwano M Nakajima, et al. 2002 Comparison between positron emission tomography and computed tomography in the use of assessment of esophageal carcinoma Cancer 94 921 928 10.1002/cncr.10330 11920459 (Pubitemid 34150845)
5. T Fukunaga S Okazumi Y Koide, et al. 1998 Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET J Nucl Med 39 1002 1007 1:CAS:528:DyaK1cXktV2itrY%3D 9627333
6. AW Blackstock MR Farmer J Lovato, et al. 2006 A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer Int J Radiat Oncol Biol Phys 64 455 460 16213103
7. SG Swisher J Erasmus M Maish, et al. 2004 2-Fluoro-2-deoxy-d-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma Cancer. 15 1776 1785 10.1002/cncr.20585 (Pubitemid 39314740)
8. RJ Downey T Akhurst D Ilson, et al. 2003 Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial J Clin Oncol 21 428 432 10.1200/JCO.2003.04.013 12560430 (Pubitemid 46606470)
9. BL Brucher W Weber M Bauer, et al. 2001 Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography Ann Surg 233 300 309 10.1097/00000658-200103000-00002 1:STN:280: DC%2BD3M7ps1emug%3D%3D 11224616 (Pubitemid 32187807)
10. Y Nishimura R Koike K Nakamatsu, et al. 2003 Concurrent chemoradiotherapy with protracted infusion of 5-FU and Cisplatin for postoperative recurrent or residual esophageal cancer Jpn J Clin Oncol 33 341 345 10.1093/jjco/hyg065 12949060 (Pubitemid 43102851)
11. JL Raoul E Le Prise B Meunier, et al. 1995 Combined radiochemotherapy for postoperative recurrence of oesophageal cancer Gut 37 174 176 10.1136/gut.37.2.174 1:STN:280:DyaK28%2FjtVKgsw%3D%3D 7557562
12. H Shimada H Kitabayashi Y Nabeya, et al. 2003 Treatment response and prognosis of patients after recurrence of esophageal cancer Surgery 133 24 31 10.1067/msy.2003.31 12563234 (Pubitemid 36183122)
13. K Nemoto H Ariga Y Kakuto, et al. 2001 Radiation therapy for loco-regionally recurrent esophageal cancer after surgery Radiother Oncol 61 165 168 10.1016/S0167-8140(01)00392-9 1:STN:280:DC%2BD3MnktFamtw%3D%3D 11690682 (Pubitemid 33016576)
14. K Nemoto H Matsushita Y Ogawa, et al. 2003 Radiation therapy combined with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for untreated and recurrent esophageal cancer Am J Clin Oncol 26 46 49 10.1097/00000421-200302000-00010 1:CAS:528:DC%2BD3sXnsFCks78%3D 12576924 (Pubitemid 36205896)
15. H Yamanaka T Motohiro T Michiura, et al. 1998 Nedaplatin and 5-FU combined with radiation in treatment for esophageal cancer Jpn J Thorac Cardiovasc Surg 10 943 948
16. K Jingu K Nemoto H Matsushita, et al. 2006 Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-Fluorouracil for postoperative locoregional recurrent esophageal cancer BMC Cancer 6 50 10.1186/1471-2407-6-50 16515704
17. R Kubota S Yamada K Kubota, et al. 1992 Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography J Nucl Med 33 1972 1980 1:CAS:528:DyaK3sXns1aktw%3D%3D 1432158
18. K Kubota J Yokoyama K Yamaguchi, et al. 2004 FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT Eur J Nucl Med Mol Imaging 31 590 595 10.1007/s00259-003-1408-6 14722678 (Pubitemid 38461575)
19. H Kato H Kuwano M Nakajima, et al. 2002 Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer Am J Surg 184 279 283 10.1016/S0002-9610(02) 00932-7 12354600 (Pubitemid 35279300)
20. M Schmidt E Bollschweiler M Dietlein, et al. 2009 Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy Eur J Nucl Med Mol Imaging 36 735 744 10.1007/s00259-008-1011- y 1:CAS:528:DC%2BD1MXkt1yms7w%3D 19096843
21. MA Lodge JD Lucas PK Marsden, et al. 1999 A PET study of 18FDG uptake in soft tissue masses Eur J Nucl Med 26 22 30 10.1007/s002590050355 1:CAS:528:DyaK1cXnvFSisrc%3D 9933658 (Pubitemid 29137735)
22. Y Nakamoto T Higashi H Sakahara, et al. 2000 Delayed (18)F-fluoro-2- deoxy-d-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas Cancer 89 2547 2554 10.1002/1097-0142(20001215)89:12<2547::AID-CNCR5>3.0.CO;2-V 1:STN:280:DC%2BD3M7gvValtg%3D%3D 11135214 (Pubitemid 32011597)
23. H Zhuang M Pourdehnad ES Lambright, et al. 2001 Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes J Nucl Med 42 1412 1417 1:STN:280:DC%2BD3Mvptlersg%3D%3D 11535734
24. A Matthies M Hickeson A Cuchiara, et al. 2002 Dual time point 18F-FDG PET for the evaluation of pulmonary nodules J Nucl Med 43 871 875 12097455
25. SY Ma LC See C Lai CH, et al. 2003 Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients J Nucl Med 44 1775 1783 14602859
26. TC Yen YC Chang SC Chan, et al. 2005 Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? Eur J Nucl Med Mol Imaging 32 541 548 10.1007/s00259-004- 1719-2 15625603 (Pubitemid 41214196)
27. P Flamen E Van Cutsem A Lerut, et al. 2002 Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer Ann Oncol 13 361 368 10.1093/annonc/mdf081 1:STN:280:DC%2BD383ls1egug%3D%3D 11996465 (Pubitemid 34704995)
28. L Kostakoglu SJ Goldsmith 2004 PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus J Nucl Med 45 56 68 14734674
29. WA Weber K Ott K Becker, et al. 2001 Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging J Clin Oncol 19 3058 3065 1:STN:280:DC%2BD3MzksFGhsQ%3D%3D 11408502
30. HA Wieder BL Brucher F Zimmermann, et al. 2004 Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment J Clin Oncol 22 900 908 10.1200/JCO.2004.07. 122 1:CAS:528:DC%2BD2cXpsVKisr8%3D 14990646 (Pubitemid 41103602)